Autopsy report · NCT01091051

Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

“Manufacturer ceased to produce vials used for this study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 33 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Innovaderm Research Inc.

Sponsor type

University, hospital or other

Conditions

Palmo-Plantar Pustular Psoriasis; Palmo-Plantar Pustulosis

Interventions

Ustekinumab; Placebo (Soduim Chloride)

Participants

33

Sites

8

Countries

Canada

Trials that died the same way

• Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
  “Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.” (73% match in meaning)
• Association of Donor Age With Recipient Outcomes in Kidney Transplant
  “Due to a lack of laboratory resources, the study was abandoned.” (69% match in meaning)
• Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
  “Discontinuation of the study Product by manufacturer” (69% match in meaning)
• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
  “Study discontinued due to futility.” (68% match in meaning)
• Epidural Technique: Does it Really Matter to the Patient?
  “This study was terminated early because of shortage of supplies with no foreseeable future of when they will be back in stock.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.